Salmonella paratyphi A is increasingly recognized as a common cause of enteric fever cases and there are no licensed vaccines against this infection. Antibodies directed against the O-polysaccharide of the lipopolysaccharide of Salmonella are protective and conjugation of the O-polysaccharide to a carrier protein represents a promising strategy for vaccine development. O-Acetylation of S. paratyphi A O-polysaccharide is considered important for the immunogenicity of S. paratyphi A conjugate vaccines.
Introduction
Salmonella enterica serovars are responsible for invasive disease in the developing world. Most cases of enteric fever are caused by Salmonella enterica serovar typhi (S. typhi). The annual global burden of disease due to typhoid fever was estimated at approximately 22 million illnesses in 2000 with a case-fatality rate of 1% resulting in more than 200,000 deaths. 1 The highest incidence was reported in South Asia, 1 and in pre-school and school-aged children. [2] [3] [4] An additional 5.4 million cases of enteric fever in 2000 were caused by Salmonella enterica serovar paratyphi A (S. paratyphi A), with children mainly affected. 1 A more recent revised estimate of the global burden of typhoid and paratyphoid fever has reported 26.9 million and 4.9 million adjusted cases of S. typhi and S. paratyphi A, respectively, in 2010. 5 S. paratyphi A is an increasingly common cause of enteric fever in the Indian subcontinent and Southeast Asia, with data suggesting it may account for up to 50% of enteric fever cases. 6 There are licensed vaccines against S. typhi, 7 but they do not offer protection against enteric fever caused by S. paratyphi A. The increasing frequency of S. paratyphi A as a cause of enteric fever and the emergence of antibiotic resistance 8 are of great concern, particularly because there are no licensed vaccines against S. paratyphi A infection. Furthermore, enteric fever caused by S. paratyphi A and S. typhi is clinically indistinguishable. As a result, in areas with high incidence of paratyphoid fever there is the risk that even a highly effective S. typhi vaccine will be poorly efficacious against enteric fever as a whole. To address enteric fever more broadly, a combination vaccine that protects against both S. typhi and S. paratyphi A would be a valuable public health tool.
The O-polysaccharide of the lipopolysaccharide (LPS) of S. paratyphi A is a potentially protective antigen and therefore the target for vaccine development. Phase 1 and 2 clinical studies with an O-polysaccharide-TT vaccine 9 were conducted 14 years ago in Vietnamese adults and children and found to be safe and immunogenic. 10 The a Phase 2 trial of this vaccine. 6, 11 Other O-polysaccharide glycoconjugates using DT and CRM 197 have been developed and tested in preclinical studies by the International Vaccine Institute (IVI) 6 and Novartis Vaccines Institute for Global Health (NVGH), respectively. 12 Both have been developed alongside Vi conjugate vaccines in order to be used in bivalent combinations and protect against both aetiologic agents of enteric fever. Salmonella LPS consists of lipid A linked to the 3-deoxy-D-manno-octulosonic acid (Kdo) terminus of a conserved core region, which is linked to the variable O-polysaccharide chain. In S. paratyphi A, the chain repeating unit consists of a trisaccharide backbone composed of rhamnose (Rha), mannose (Man) and galactose (Gal), with a terminal paratose (Par) at C-3 of Man (which confers serogroup specificity: factor 2) and terminal glucose (Glc) at C-6 of Gal (Fig. 1) .
A common feature shared by various O-polysaccharides is the presence of decorations such as O-acetyl groups. It has been reported that not only the presence but also the position of Oacetyl groups in the O-polysaccharide may influence the immune response. 13 The S. paratyphi A O-polysaccharide was reported to require O-acetyl groups in order to elicit serum LPS antibody with bactericidal activity in mice. 9 In the case of S. paratyphi A, a single site of O-acetylation has been reported, on C-3 of the Rha residue as part of the repeating O-polysaccharide chain 9,10,14,15 or on C-2 of the same monomer. 16 However, from analysis of the 13 C NMR spectrum, Konadu et al. suggested the presence of two different O-acetyl groups, the second one on the Par residue, akin to that found on C-2 of abequose for S. typhimurium. 17 The authors highlighted the need for further investigation given the important role that O-acetyl groups seem to play in immunogenicity. 9, 10 In the O-polysaccharide purification strategy adopted by NVGH, the labile linkage between the Kdo of the core and the lipid A is cleaved directly in the bacterial growth medium; 18 the O-polysaccharide, still linked to the core, is then easily purified from the cells and can be used for the production of conjugate vaccines. For conjugation to CRM 197 , the S. paratyphi O-polysaccharide is linked to the carrier protein through the terminal Kdo, with the aim to preserve the O-polysaccharide antigen structure. 12 Here the O-polysaccharide structure has been elucidated by use of HPLC-SEC, HPAEC-PAD/CD, GLC, GLC-MS and 1D and 2D NMR studies. Heterogeneity due to non-stoichiometric glucosylation and O-acetylation resulted in complex NMR spectra and simpler structures were chemically derived to facilitate full assignment of the native O-polysaccharide structure. In particular, the presence of O-acetyl groups on both C-2 and C-3 of Rha was identified. The same pattern of O-acetylation was found in the O-polysaccharide-CRM 197 conjugate and on the surface carbohydrate of S. paratyphi A bacteria. This confirmed that the purification and the conjugation processes do not alter the structure of the O-polysaccharide antigen, including retention of O-acetyl groups considered important for the immunogenicity of the S. paratyphi A vaccine. H NMR spectrum of the OPS confirmed the presence of the two deoxy sugars with diagnostic signals for the H-3s of Par and H-6 of Rha (split) and Par, but the anomeric region could not be readily assigned due to overlap and the presence of multiple peaks. The complexity of the OPS spectrum was attributed to the twinning of some signals from incomplete glucosylation and the presence of both the pentasaccharide (major) and tetrasaccharide (minor) repeating units. This was further exacerbated by additional twinning of signals due to partial O-acetylation (shown by signals at 2.20 and 2.18 ppm) and the presence of small peaks from the core region and process residuals. Elucidation of these complex NMR spectra was achieved after full assignment of the 1 H and 13 C NMR spectra of simpler saccharides derived from OPS.
Characterization of OPS Smith degradation products
Complete periodate oxidation of OPS, followed by reduction with NaBH 4 and mild acid hydrolysis (Smith degradation) yielded an oligosaccharide (OPS-S1) as the major product. Full assignment of OPS-S1 aided in the NMR interpretation of the polymer obtained after partial Smith degradation to reduce the level of glucosylation (OPS-S2), which in turn facilitated elucidation of the de-O-acetylated OPS (OPS-D) spectra and finally the spectra obtained for OPS.
The permethylated OPS-S1 gave the mass spectrum ( Table S1 . Identification of OPS-S1 as a-
2-1dEry-ol followed from detailed 1D and 2D NMR analysis (Supplementary data). A second Smith degradation using partial periodate oxidation of OPS was performed in order to selectively remove the t-Glc residue and thereby increase the proportion of the tetrasaccharide repeating unit in the OPS preparation. Composition analysis by GLC of the alditol acetates derivatives gave Rha/Man/Gal/Glc in the relative molar ratios 0.66:1.00:1.03:0.44, thus indicating a successful partial removal of the t-Glc, but also some depletion of the Rha residue. As Rha is a backbone residue, its decrease would be associated with some in-chain cleavage and result in a lower molecular mass of the sample. Therefore, the partial Smith degradation product was separated on a Sephacryl S-300 size exclusion column and only the fractions with the higher molecular mass were pooled together to yield the polymeric OPS-S2 sample containing lower levels of glucosylation.
Assignment of the NMR spectra of OPS-D
The 1 H NMR spectra of OPS-S1, OPS-S2 and OPS-D are shown in Figure S2 and the corresponding 13 C NMR spectra in Figure S3 . Elucidation of the sugar spin systems for the pentasaccharide repeating unit (major component, RU5, residues in upper case) and tetrasaccharide repeating unit (minor component, RU4, residues in lower case) for OPS-D was achieved using the 1D and 2D NMR experiments previously applied to OPS-S1 (Supplementary data).
The NMR study was hampered by the presence of heterogeneity leading to signal overlap, and although the terminal Glc and Par residues gave relatively sharp signals (and their spin systems were readily assigned), those from the backbone residues, particularly the 2,3-linked Man, gave broad signals and poor crosspeaks in the 2D NMR spectra. These problems were overcome by extensive use of hybrid experiments (HSQC-TOCSY and HSQC-NOESY) and by repeating the NMR study using a high field spectrometer (600 MHz). Comparison of the 1D 1 H NMR spectra of OPS-S2 and OPS-D (Fig. S2B and C) confirmed that OPS-S2 contains a lower level of Glc compared to OPS-D ($25% vs $80%). The largest visible effect of glucosylation was experienced by the anomeric signals of Man [5.30 ppm (C-1 at 100.3 ppm) in RU4 shifts to 5.18 ppm (C-1 at 100.7 ppm) in RU5] and this is the main source of spectral complexity in the anomeric region (see HSQC expansion, Fig. 2A ). Once this was realized, the five major spin systems were identified by tracing correlations starting from H-1 (all), H-3 (Par) and H-6 (Par and Rha) resonances in COSY and TOCSY experiments and the corresponding carbons through use of HSQC, HSQC-TOCSY and HMBC experiments. The 1 H and 13 C NMR data are collected in Table 1 . Ambiguities in tracing out the Man (M) spin systems were solved as for OPS-S1, by the HMBC crosspeaks from H-1 Man at 5.18 ppm to C-2 (small), C-3 and C-5 and the linkage shown by the crosspeak from H-1 to C-4 Rha (82.1 ppm). The spin system for the Man (m) from RU4 showed the same carbon correlations from H-1 at 5.30 ppm, indicating that the effect of glucosylation is mainly experienced by the anomeric position. The twinning of the H-6/C-6 crosspeaks for Rha due to glucosylation (1.32:17.7 ppm for r in RU4 and 1.34:17.9 ppm for R in RU5) provided a useful window for elucidation of these spin systems using the HSQC-TOCSY and HMBC experiments. Here the twinning of signals was detectable for H-5, H-4 and H-1/C-1 (Table 1 and (Fig. 1) . Modelling studies were performed to account for the major chemical shift influence observed from glucosylation (H-1 Man and H-4 to H-6 Rha); the favored orientations of phi/psi dihedral angles for each of the glycosidic linkages in the pentasaccharide repeating unit bring Glc in close proximity to the Man and Rha backbone residues. 19 Additional crosspeaks were observed corresponding to small peaks in the 1D spectra derived from the core oligosaccharide as well as the non-reducing terminal of the OPS a-D-Parp- 
Chemical and NMR characterization of OPS O-acetylation
The pattern of O-acetylation of OPS was investigated chemically and by use of NMR spectroscopy. OPS was permethylated following the method of Prehm, 22 which leaves the O-acetyl groups in their native positions, thus allowing the determination of their location. GLC chromatograms of the PMAA derivatives for the Opolysaccharide obtained without (A) and with (B) retention of the O-acetyl groups (Fig. 3) showed the presence of two new peaks corresponding to 3,4-linked Rha and 2,4-linked Rha and a decrease in the peak intensity of 4-linked Rha. Although the peaks corresponding to 4-Rha and t-Glc overlap on the SP2330 column, integration of the signals corresponding to the new Rha derivatives indicated that the 34% of the 4-linked Rha was acetylated on C-3 and 25% on C-2 ( Table 2) . Subsequent GLC-MS of the samples on OPS-D: the residues of the major pentasaccharide repeating unit are indicated by upper case (e.g. Gal = GA) and the minor tetrasaccharide repeating unit by lower case (e.g. Gal = GA). Deshielded ring carbons (linkage positions) are underlined. The spectra were recorded at 303 K (600 MHz) and referenced to residual sodium acetate (present after de-O-acetylation). OPS: only the residues of the pentasaccharide repeating unit affected by O-acetylation are presented; minor peaks due to the presence of the tetrasaccharide repeating unit are not listed. The Rha, Rha3Ac and Rha2Ac spin systems are represented by R, R 0 and R 00 , respectively, and the corresponding spin systems of Man by M, M 0 and M 00 . The NMR spectra were recorded at 303 K (600 MHz) and referenced to DMSO. (Fig. 4A) , not present in OPS-D (Fig. S2C ); these were attributed to the two O-acetyl groups detected chemically. An overlay of the 13 C NMR spectra of OPS and OPS-D (Fig. 5) showed a decrease in intensity of the Rha (R) signals and the appearance of several new signals attributed to Rha3Ac (R 0 ) and Rha2Ac (R 00 ). These spin systems were assigned using a full array of 2D experiments; a combination of the HSQC-NOESY (Fig. 6A ) and HSQC-TOCSY (Fig. 6B ) experiments were particularly useful in establishing connectivities from the O-acetyl signals (at 2.20 and 2.18 ppm) and the H-6/C-6 resonances, respectively, to the carbons of the Rha3Ac (R 0 ) and Rha2Ac (R 00 ) residues. Initial studies indicated a single position of O-acetylation manifest by a single HSQC crosspeak as recently reported. 15 However, repeating the NMR study at higher field (600 MHz) revealed the presence of overlapping crosspeaks due to Rha3Ac (major, R 0 at 5.19/ 73.4 ppm) and Rha2Ac (minor, R 00 at 5.20/73.5 ppm). The HMBC experiment permitted identification of the acetyl carbons (at 174.1 and 173.9 ppm) from the signals at 2.20 and 2.18 ppm, and the carbonyls gave small crosspeaks to the corresponding ring protons in the anomeric region. The NMR data are collected in Table 1 . For Rha3Ac, the presence of the O-acetyl group on C-3 resulted in deshielding of H-3 (+1.23 ppm) and C-3 (+3.6 ppm) and shielding of the adjacent carbons C-2 (À2.2 ppm) and C-4 (À3.5 ppm), whereas for Rha2Ac, H-2 (+1.13 ppm) and C-2 (+2.4 ppm) were deshielded and the adjacent carbons C-1 (À2.9 ppm) and C-3 (À1.6 ppm) shielded. The effects of O-acetylation on Rha are comparable to those reported for ?4)-a-Rha2/3Ac in Salmonella typhimurium 21 and a strain of Aeromonas sobria. 23 The major effect connectivity to the O-polysaccharide repeating unit could not be established and the peak is absent from the NMR spectrum of OPS-CRM 197 . This peak could explain the higher total O-acetylation levels determined by NMR after in-tube de-O-acetylation or HPAEC-PAD compared to NMR analysis of the intact O-acetylated O-polysaccharide.
HR-MAS NMR analysis on bacterial pellets confirming Oacetylation pattern found on purified OPS
The O-acetylation pattern of O-polysaccharide expressed on surface of bacteria was also investigated in light of literature reports regarding a single position of O-acetylation and the possibility that the O-acetylation observed on C-2 and C-3 of Rha of OPS may arise from migration during O-polysaccharide preparation. HR-MAS NMR analysis, used to track the pattern of O-acetylation on live Salmonella typhimurium bacteria, 24 was performed on bacterial pellets from three clinical isolates and a genetically modified S. paratyphi A strain. The 1 H NMR spectra obtained (Fig. 7A-D) showed that all cells contain two peaks ($1:1 ratio) in the O-acetyl region assigned to O-acetylation on C-2 and C-3 of Rha. This proves that O-acetylation on both positions is common to different S. paratyphi A strains and it is not an artefact introduced during Opolysaccharide isolation and purification, corroborated by a comparison of the O-acetylation on the surface of bacteria (Fig. 7D ) and on the O-polysaccharide purified from the homologous strain (Fig. 7E) . Purified OPS has O-acetylation of 30% and 18% at positions C-3 and C-2 of Rha (compared to H-6 of Rha), suggesting that although some migration may occur during O-polysaccharide purification, it results in a consistent 3:2 ratio at positions C-3 and C-2 of Rha. The facile migration between positions C-2 and C-3 has been reported for methyl glycosides of O-acetylated a-L-Rhap. 25 
Conclusions
As part of a project to develop a bivalent conjugate vaccine against both S. typhi and S. paratyphi A infections, we have fully characterized the O-polysaccharide from S. paratyphi A. Sugar analysis by GLC-MS confirmed the composition of the tetrasaccharide repeating unit as Man, Gal, Rha and Par together with non-stoichiometric amounts ($75%) of glucosylation; this is in agreement with HPAEC-PAD data previously reported. 18 The structure of the 
Samples
OPS was purified as previously described. 18 All preparations were characterized by protein content <1% (mg/mg OPS; by micro BCA), nucleic acid content <0.5% (mg/mg OPS; by absorption at 260 nm) and endotoxin level <0.1 UI/lg (by LAL).
De-O-acetylation of OPS was performed in the NMR tube, however the higher pH and ionic strength resulted in minor chemical shift differences with the parent OPS sample that hampered direct comparison of the spectra. Therefore the OPS-D sample was obtained by de-O-acetylation of the O-polysaccharide sample (200 mM NaOH at 37°C for 2 h) followed by recovery of the sample by freeze-drying after dialysis against water.
The O-polysaccharide conjugate (OPS-CRM 197 ) was prepared as previously described. 12 Briefly the sugar chain was linked to adipic acid dihydrazide (ADH) by reductive amination through the ketone group of its terminal Kdo sugar. An additional linker, SIDEA, was then attached to ADH before conjugation to the carrier protein. The conjugate prepared for this structural analysis was characterized by a saccharide to CRM 197 w/w ratio of 2.7, with no free CRM 197 detectable (by HPLC-SEC) 12 and less than 10% free saccharide (following precipitation of the conjugate with deoxycholate). 26 
Smith degradation of OPS to yield OPS-S1 and OPS-S2
OPS was subjected to complete oxidation with NaIO 4 , 27,28 by dissolving 180 mg of the sample in 50 mL of 30 mM NaIO 4 and incubating at 10°C for 7 days in the dark. The reaction was stopped by the addition of glycerol and the products were reduced with NaBH 4 . Addition of 50% CH 3 COOH after 16 h destroyed the excess of reducing reagent, the sample was dialysed and the solution volume subsequently reduced to 10 mL. TFA was added in order to have a final concentration of 0.1 M and the hydrolysis was conducted at room temperature for 7 days. The solution was taken to dryness under reduced pressure, dissolved in water, its pH adjusted to neutrality, and the product was recovered by lyophilization. It was then separated on a Bio Gel P2 column (1.6 cm i.d. Â 90 cm) equilibrated in 50 mM NaNO 3 which was also used as eluent. The flow rate was 6 mL/h and fractions were collected at 15 min intervals. Elution was monitored using a refractive index detector (WGE Dr. Bures, LabService Analitica) connected to a paper recorder and interfaced with a computer via picolog software. One major oligosaccharide, named OPS-S1, was obtained from the chromatographic separation and analysed by NMR and ESI-MS. OPS was also subjected to partial periodate oxidation in order to selectively remove the t-Glc residue: 21 mg of sample were dissolved in 7 mL of 16 mM NaIO 4 and stirred for 75 min at 10°C in the dark. The oxidation was then stopped by addition of glycerol and the products were treated as reported above. Reduction of the aldehyde groups with NaBH 4 resulted in de-O-acetylation. After a mild hydrolysis for 7 days with 0.05 M TFA, the sample was taken to dryness under reduced pressure in order to remove most of the acid, then taken to neutral pH and recovered by lyophilization. The sample was subjected to composition analysis and then separated on a Sephacryl S-300 column (1.6 cm i.d. Â 92 cm), equilibrated in 50 mM NaNO 3 and using the same solution as eluent. The flow rate was 6 mL/h and fractions were collected at 15 min intervals. Elution was monitored as reported above for the sample OPS-S1. The fractions with the highest molecular mass were pooled together, named OPS-S2 and investigated by NMR spectroscopy.
Chemical analysis
Analytical GLC was performed on a Perkin Elmer Autosystem XL gas chromatograph equipped with a flame ionization detector and an SP2330 capillary column (Supelco, 30 m), using He as carrier gas. The following temperature programmes were used: for alditol acetates, 200-245°C at 4°C/min; for partially methylated alditol acetates, 150-250°C at 4°C/min. Separation of the trimethylsilylated (+)-2-butyl glycosides was obtained on a HP-1 column (Hewlett-Packard, 50 m), using the following temperature programme: 50°C 1 min, 50-130°C at 45°C/min, hold 1 min, 130-240°C at 1°C/min, hold 20 min. GLC-MS analyses were carried out on an Agilent Technologies 7890A gas chromatograph coupled to an Agilent Technologies 5975C VL MSD. Hydrolysis of the samples was performed with 2 M TFA for 1 h at 125°C. Alditol acetates were prepared as already described. 29 Permethylation of polysaccharides and oligosaccharides was achieved following the protocols by Harris 30 and Dell, 31 respectively. The method of Prehm was used to methylate OPS without removal of O-acetyl groups. 22 Determination of the absolute configuration of the sugar residues was performed as described. 32 Quantification of total O-acetylation was performed by use of high-performance anion-exchange chromatography with conductivity detection (HPAEC-CD). OPS samples (total volume of 225 lL) were added with 25 lL of 200 lg/mL sodium propionate in 100 mM NaOH. The samples were heated at 37°C for 4 h. Samples were then filtered with 0.45 lm Acrodisc (PALL) filters before chromatographic analysis. Calibration curve was built using sodium acetate as standard in the range of 0.5-10 lg/mL. The standards were treated and analysed as described for the samples. HPAEC-CD was performed with a Dionex ICS3000 equipped with a Dionex IonPac AS11 (4 Â 250 mm) coupled with IonPac AG11 Guard Column (4 Â 50 mm) and quantified by a conductivity detector with ASRS suppressor under 2 mM NaOH elution.
ESI MS analysis
ESI mass spectra were recorded on a Bruker Esquire 4000 ion trap mass spectrometer connected to a syringe pump for the injection of the samples. The instrument was calibrated using a tune mixture provided by Bruker. Permethylated samples were dissolved in chloroform/methanol/0.75 M NH 4 OAc 1:1:0.03 (v/v/v) at an appropriate concentration and injected at 180 lL/h. Detection was always performed in the positive ion mode.
NMR spectroscopy
Samples of OPS [90 mg (400 MHz study) and 20 mg (600 MHz study)], OPS-D (70 mg), OPS-S1 (10 mg), OPS-S2 (6 mg) and 
